CME Group (CME) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts CME Hot Sheet
Price: $276.01 +1.79%
Revenue Growth %: +12.7%
Financial Fact:
Licensing and other fee agreements: 31.5M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +12.7%
Financial Fact:
Licensing and other fee agreements: 31.5M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
CME Group (NASDAQ: CME) reported Q2 EPS of $0.95, $0.07 better than the analyst estimate of $0.88. Revenue for the quarter came in at $820 million versus the consensus estimate of $783.74 million.
For earnings history and earnings-related data on CME Group (CME) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- B.Riley Assumes Anika Therapeutics (ANIK) at Buy
- Redburn upgrades Southwest, stays bullish on Delta and United
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
